EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Disease and Condition

AlphaRx' Tuberculosis Drug Development Program Gaining Momentum

U.S. Civilian Research and Development Foundation awarded a grant to scientists at the National Jewish Medical and Research Center, the Russian Research Center of Molecular Diagnostics and Therapy, and AlphaRx Inc. under the title "Development of the Drug Delivery Systems for Anti-Tuberculosis Drugs Based on Colloidal Lipid Nanoparticles".

Improved Meningitis Vaccine For Africa Could Signal Eventual End To Deadly Scourge

Performance of a meningitis vaccine in West African children, suggesting that the new vaccine - expected to sell initially for 40 US cents a dose - will be much more effective in protecting African children and their communities than any other vaccine.

VELCADE Plus DOXIL Improves Survival In Previously Treated Patients With Multiple Myeloma

International Myeloma Foundation said that data from a follow-up to a Phase 3 multi-national clinical trial shows the combination of DOXIL with VELCADE improves the probability of myeloma patients' survival by 41%.

Pages